Status:
UNKNOWN
Association Between S-LAAO and Adverse Cardiovascular Events Among Patients Undergoing Coronary Artery Bypass Grafting.
Lead Sponsor:
Beijing Institute of Heart, Lung and Blood Vessel Diseases
Conditions:
Heart Surgery
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
This is a prospective, single-center, randomized, active controlled, clinical trail to assess the efficacy and safety of surgical closure of left atrial appendage (LAA) in patients undergoing coronary...
Eligibility Criteria
Inclusion
- Subject undergoing coronary artery bypass grafting according to clinical indications;
- Age is more than 18 and less than 80 years old;
- Male and non pregnancy female;
- Subject understands study requirements and agrees to sign an informed consent from prior to study procedures.
Exclusion
- Pregnancy female;
- Participate in other clinical trial in the last 1 month.
- Subject doesn't agree to sign an informed consent from prior to study procedures.
- Subject undergoing repeat CABG, concomitant valve or other cardiac surgery.
- New York Heart Association (NYHA) Class IV heart failure.
Key Trial Info
Start Date :
October 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 1 2023
Estimated Enrollment :
240 Patients enrolled
Trial Details
Trial ID
NCT04108169
Start Date
October 1 2019
End Date
January 1 2023
Last Update
September 30 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Beijing Anzhen Hospital
Beijing, China, 100029